• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈症中的神经炎症与神经退行性变:遗传特征、金属及有机磷酸酯的作用

Neuroinflammation and neurodegeneration in Huntington's disease: genetic hallmarks, role of metals and organophosphates.

作者信息

Kunwar Omkar Kumar, Singh Shamsher

机构信息

Neuropharmacology Division, Department of Pharmacology, ISF College of Pharmacy, Moga, Punjab, 142001, India.

出版信息

Neurogenetics. 2025 Jan 17;26(1):21. doi: 10.1007/s10048-025-00801-2.

DOI:10.1007/s10048-025-00801-2
PMID:39820855
Abstract

Huntington's disease (HDs) is a fatal, autosomal dominant, and hereditary neurodegenerative disorder characterized by progressive motor dysfunction, cognitive decline, and psychiatric disturbances. HD is well linked to mutation in the HTT gene, which leads to an abnormal expansion of trinucleotide CAG repeats, resulting in the production of the mHTT protein and responsible for abnormally long poly-Q tract. These abnormal proteins disrupt cellular processes, including neuroinflammation, endoplasmic reticulum (ER) stress, and mitochondrial dysfunction, ultimately leading to selective neuronal loss in the brain. Epidemiological studies reveal significant regional variability in HDs prevalence, with the highest rates observed in North America and the lowest in Africa. In addition to genetic factors, environmental influences such as exposure to metals, and chemicals, and lifestyle factors like alcohol and tobacco use may exacerbate disease progression. This review explores the molecular mechanisms underlying HDs and emphasize the role of neuroinflammatory mediators and environmental factors, in HD research. Understanding these complex interactions is crucial for developing targeted interventions that can slow or halt the progression of this devastating disease.

摘要

亨廷顿舞蹈症(HDs)是一种致命的常染色体显性遗传性神经退行性疾病,其特征为进行性运动功能障碍、认知衰退和精神障碍。HD与HTT基因突变密切相关,该突变导致三核苷酸CAG重复序列异常扩增,产生突变型亨廷顿蛋白(mHTT)并形成异常长的多聚谷氨酰胺链。这些异常蛋白质扰乱细胞进程,包括神经炎症、内质网应激和线粒体功能障碍,最终导致大脑中神经元选择性丢失。流行病学研究显示,HDs患病率存在显著的地区差异,北美地区患病率最高,非洲地区最低。除遗传因素外,接触金属和化学物质等环境影响以及饮酒和吸烟等生活方式因素可能会加剧疾病进展。本综述探讨了HDs的分子机制,并强调了神经炎症介质和环境因素在HD研究中的作用。了解这些复杂的相互作用对于开发能够减缓或阻止这种毁灭性疾病进展的靶向干预措施至关重要。

相似文献

1
Neuroinflammation and neurodegeneration in Huntington's disease: genetic hallmarks, role of metals and organophosphates.亨廷顿舞蹈症中的神经炎症与神经退行性变:遗传特征、金属及有机磷酸酯的作用
Neurogenetics. 2025 Jan 17;26(1):21. doi: 10.1007/s10048-025-00801-2.
2
The role of mitochondrial dysfunction in Huntington's disease: Implications for therapeutic targeting.线粒体功能障碍在亨廷顿舞蹈病中的作用:对治疗靶点的启示。
Biomed Pharmacother. 2025 Feb;183:117827. doi: 10.1016/j.biopha.2025.117827. Epub 2025 Jan 23.
3
Multiple clinical features of Huntington's disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration.亨廷顿病的多种临床特征与突变 HTT 基因 CAG 重复长度和神经退行性变相关。
J Neurol. 2019 Mar;266(3):551-564. doi: 10.1007/s00415-018-8940-6. Epub 2018 Jun 28.
4
Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.小分子蛋白二硫键异构酶调节剂可减轻亨廷顿病模型小鼠中突变型亨廷顿蛋白的毒性,并抑制内质网应激。
Hum Mol Genet. 2018 May 1;27(9):1545-1555. doi: 10.1093/hmg/ddy061.
5
Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.亨廷顿病相关行为、细胞和病理特征的促进:亨廷顿病基因缺失在神经节内侧和外侧谱系中差异破坏区域中间神经元和投射神经元亚型。
J Neurosci. 2019 Mar 6;39(10):1892-1909. doi: 10.1523/JNEUROSCI.2443-18.2018. Epub 2019 Jan 9.
6
Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.亨廷顿病猴诱导多能干细胞源性神经祖细胞衍生的星形胶质细胞改善亨廷顿病表型。
PLoS One. 2019 Mar 21;14(3):e0214156. doi: 10.1371/journal.pone.0214156. eCollection 2019.
7
Leucine 7 is a key residue for mutant huntingtin-induced mitochondrial pathology and neurotoxicity in Huntington's disease.亮氨酸7是亨廷顿病中突变型亨廷顿蛋白诱导的线粒体病理和神经毒性的关键残基。
J Biol Chem. 2025 Mar;301(3):108297. doi: 10.1016/j.jbc.2025.108297. Epub 2025 Feb 11.
8
Neuroinflammatory Proteins in Huntington's Disease: Insights into Mechanisms, Diagnosis, and Therapeutic Implications.亨廷顿病中的神经炎症蛋白:对发病机制、诊断和治疗意义的深入了解。
Int J Mol Sci. 2024 Nov 2;25(21):11787. doi: 10.3390/ijms252111787.
9
Molecular Pathogenesis in Huntington's Disease.亨廷顿舞蹈症的分子发病机制
Biochemistry (Mosc). 2018 Sep;83(9):1030-1039. doi: 10.1134/S0006297918090043.
10
Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.下调与突触功能相关的神经胶质基因可减轻亨廷顿病的发病机制。
Elife. 2021 Apr 19;10:e64564. doi: 10.7554/eLife.64564.

引用本文的文献

1
Anti-inflammatory and antioxidant effects of baicalein: targeting Nrf2, and NFĸB in neurodegenerative disease.黄芩素的抗炎和抗氧化作用:在神经退行性疾病中靶向核因子E2相关因子2(Nrf2)和核因子κB(NFĸB)
Inflammopharmacology. 2025 Mar;33(3):1303-1310. doi: 10.1007/s10787-025-01698-x. Epub 2025 Feb 27.
2
Advances in Huntington's Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive Review.亨廷顿舞蹈症生物标志物的进展:十年文献计量分析与综合综述
Biology (Basel). 2025 Jan 26;14(2):129. doi: 10.3390/biology14020129.

本文引用的文献

1
Heavy Metal Interactions with Neuroglia and Gut Microbiota: Implications for Huntington's Disease.重金属与神经胶质细胞和肠道微生物群的相互作用:对亨廷顿病的影响。
Cells. 2024 Jul 3;13(13):1144. doi: 10.3390/cells13131144.
2
Sex contribution to average age at onset of Huntington's disease depends on the number of (CAG) repeats.性别的影响取决于亨廷顿病发病年龄的(CAG)重复次数。
Sci Rep. 2024 Jul 8;14(1):15729. doi: 10.1038/s41598-024-64105-5.
3
Neuroimmune pathways involvement in neurodegeneration of R6/2 mouse model of Huntington's disease.
神经免疫途径参与亨廷顿舞蹈病R6/2小鼠模型的神经退行性变。
Front Cell Neurosci. 2024 Feb 20;18:1360066. doi: 10.3389/fncel.2024.1360066. eCollection 2024.
4
Huntington's disease prevalence in Asia: a systematic review and meta-analysis.亚洲亨廷顿病的患病率:系统评价和荟萃分析。
Riv Psichiatr. 2024 Jan-Feb;59(1):4-12. doi: 10.1708/4205.41943.
5
Rodent Models of Huntington's Disease: An Overview.亨廷顿舞蹈症的啮齿动物模型:综述
Biomedicines. 2023 Dec 16;11(12):3331. doi: 10.3390/biomedicines11123331.
6
A clinical study and future prospects for bioactive compounds and semi-synthetic molecules in the therapies for Huntington's disease.亨廷顿舞蹈症治疗中生物活性化合物和半合成分子的临床研究及未来前景
Mol Neurobiol. 2024 Mar;61(3):1237-1270. doi: 10.1007/s12035-023-03604-4. Epub 2023 Sep 12.
7
Neuroprotective potency of mangiferin against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats: possible antioxidant and anti-inflammatory mechanisms.芒果苷对3-硝基丙酸诱导的大鼠亨廷顿病样症状的神经保护作用:可能的抗氧化和抗炎机制
Front Pharmacol. 2023 Jul 13;14:1189957. doi: 10.3389/fphar.2023.1189957. eCollection 2023.
8
Neuromodulation in Parkinson's disease targeting opioid and cannabinoid receptors, understanding the role of NLRP3 pathway: a novel therapeutic approach.帕金森病中靶向阿片类和大麻素受体的神经调节,了解 NLRP3 通路的作用:一种新的治疗方法。
Inflammopharmacology. 2023 Aug;31(4):1605-1627. doi: 10.1007/s10787-023-01259-0. Epub 2023 Jun 15.
9
Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.阿尔茨海默病、帕金森病、亨廷顿病和肌萎缩侧索硬化症中的线粒体功能障碍和氧化应激——最新综述。
Mitochondrion. 2023 Jul;71:83-92. doi: 10.1016/j.mito.2023.05.007. Epub 2023 Jun 1.
10
An Overview of the Pathophysiological Mechanisms of 3-Nitropropionic Acid (3-NPA) as a Neurotoxin in a Huntington's Disease Model and Its Relevance to Drug Discovery and Development.3-硝基丙酸(3-NPA)作为亨廷顿舞蹈病模型中的神经毒素的病理生理机制概述及其与药物发现和开发的相关性
Neurochem Res. 2023 Jun;48(6):1631-1647. doi: 10.1007/s11064-023-03868-1. Epub 2023 Feb 4.